Disclosure of Conflicts of Interest

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Faculty

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity

Sara Alexanian, MD, Faculty, has no relevant financial relationships to disclose.

Lisa Caruso, MD, MPH, Faculty, has no relevant financial relationships to disclose.

Samar Hafida, MD, Co-Course Director, has no relevant financial relationships to disclose.

Kevin J. Horbowicz, PharmD, BCPS, Faculty, has disclosed that he has individual publicly traded stocks and stock options from Merck.

Linda Baer, MSPH, CHCP, Planner, has no relevant financial relationships to disclose.

Emily Jansen, MPH, Planner, has no relevant financial relationships to disclose.

Lorena Loci, MSN, NP, Content Co-Chair, Nurse Advisor, has no relevant relationships to disclose.

Katelyn O’Brien, PharmD, Content Co-Chair, has no relevant relationships to disclose.

Ivania Rizo, MD, Co-Course Director, has no relevant financial relationships to disclose.

Charles T. Williams, MD, Faculty, has no relevant relationships to disclose.

Natalie Sanfratello, MPH, Planner, has no relevant financial relationships to disclose.

Sophia Kelley, MBA, Planner, has no relevant financial relationships to disclose.

Cara Blair, Planner, has no relevant financial relationships to disclose.

Ruth Cohen, Planner, has no relevant financial relationships to disclose.

Robin Black, PharmD, Planner, has no relevant financial relationships to disclose.

Dave Faldmo, PA-C, MPAS, Planner, has no relevant financial relationships to disclose.

Corinne Aia, MS, RD, CDCES Planner, has no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.